JOURNAL ARTICLE

Are unknown co-medications, over-the-counter and off-label drug use still problems among people living with HIV? Results from a transversal survey in 23 centres in France.

  • Published In: Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 11. P. 2731 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Tetart, Macha; Passecountrin, Priscila; Lesourd, Anaïs; Sanderink, Diane; Moal, Gwenaël Le; Surgers, Laure; Beraud, Guillaume; Katlama, Christine; Robineau, Olivier; Parienti, Jean-Jacques; group, the COMEDWEEK Study 3 of 3

Abstract

This article focuses on the prevalence and impact of co-medications and potential drug–drug interactions (DDIs) among people living with HIV (PLHIV) in France. In a national cross-sectional study of 496 adult PLHIV receiving antiretroviral therapy (ART), 79% reported taking co-medications, with 17% experiencing polypharmacy (≥5 medications), and 32% having co-medications unknown to their HIV physicians. Potential DDIs were identified in 11% of participants, leading to treatment modifications in nearly half of these cases, regardless of age group. The study highlights the need for systematic assessment of all medications, including over-the-counter and illicit drugs, by healthcare providers to better manage DDIs in PLHIV.

Additional Information

  • Source:Journal of Antimicrobial Chemotherapy (JAC). 2023/11, Vol. 78, Issue 11, p2731
  • Document Type:Article
  • Subject Area:Life Sciences
  • Publication Date:2023
  • ISSN:0305-7453
  • DOI:10.1093/jac/dkad292
  • Accession Number:173433099
  • Copyright Statement:Copyright of Journal of Antimicrobial Chemotherapy (JAC) is the property of Oxford University Press / USA and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.